Smart implants — orthopedic devices with embedded sensors capable of measuring load, motion, temperature, and physiological parameters — represent the frontier of implant technology innovation. OrthoSensor's VERASENSE tibial sensor platform for intraoperative soft tissue balancing in total knee arthroplasty has been the leading commercial smart implant application. The next generation of truly connected implants — capable of continuous post-implantation data transmission — is advancing through clinical development.
This report provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs.
Topics Covered
• Intraoperative Sensor Technology
• VERASENSE and Competing Platforms
• Post-Implantation Connected Implants
• Data Transmission Technology
• Clinical Applications
• Regulatory Pathway
• Commercial Landscape
Table of Contents
1. Executive Summary
2. Technology Landscape Overview
3. Intraoperative Sensor Technology
4. VERASENSE and Competing Platforms
5. Post-Implantation Connected Implants
6. Data Transmission Technology
7. Clinical Applications
8. Regulatory Pathway
9. Commercial Landscape
10. Competitive Landscape
11. Strategic Conclusions and Recommendations
12. Appendix
List of Tables
Table 1. Technology Overview and Key Data 2025
Table 2. Intraoperative Sensor Technology
Table 3. VERASENSE and Competing Platforms
Table 4. Post-Implantation Connected Implants
Table 5. Data Transmission Technology
Table 6. Clinical Applications
Table 7. Regulatory Pathway
Table 8. Commercial Landscape
Table 9. Leading Companies — Technology Investment and Strategy 2025
Table 10. M&A and Partnership Activity 2023-2025
Table 11. Key Risks and Mitigation Strategies
Companies Profiled
Aesculap
Arthrex
DePuy Synthes
Enovis
Globus Medical
NuVasive
Smith & Nephew
Stryker
Wright Medical
Zimmer Biomet
